Research helping combat drug addiction

(Medical Xpress) -- Better help with battling drug addiction could be at hand as a result of research underway at Victoria University of Wellington.

Dr Bronwyn Kivell, a Senior Lecturer in the School of Biological Sciences, is screening a number of anti-addiction compounds that may ultimately form the basis of medications that help reduce cravings and prevent for people addicted to psychostimulants such as or .

Collaborating with a medicinal chemist at the University of Kansas in the United States along with her Victoria University colleague Professor Susan Schenk, Dr Kivell is investigating ways of targeting a in the brain, called the kappa , which can alter a person’s perception of mood, reward and pain.

The researchers are focused on a Mexican herb called salvia divinorum, also known as Mexican or Tijuana tripping weed, a powerful hallucinogen that has been chewed by Mexican Indians for centuries.

Most hallucinogenic substances affect serotonin, a neurotransmitter in the body that influences people’s sense of well-being, but Dr Kivell says salvia is different.

"It has a unique structure and contains compounds that we think could have anti-addictive properties."

The compounds are being developed at the University of Kansas and tested at Victoria University.

A usual problem with compounds that target kappa opioid receptors, says Dr Kivell, is their tendency to have extreme side effects such as nausea and depression.

"However, some of those we are testing have much milder side effects."

Another strand of Dr Kivell’s research targets more effective therapies to help people stop smoking. She says while nicotine is the major addictive component in cigarettes, there are many other things in cigarette smoke that contribute to addiction.

Her research, being carried out with Crown Research Institute ESR (Institute of Environmental Science and Research), is studying the role of a number of minor tobacco alkaloids.

"Most tools to help people quit smoking are based on nicotine replacement and have relatively low success rates. Our goal is to work out if it is feasible to develop other anti-smoking aids that target proteins in the brain that are involved in addiction."

Dr Kivell, who completed her PhD at Victoria, has also carried out research at the National Institute on Drug Abuse in Baltimore in the United States.

She returned to Victoria to work on a ground-breaking project that is looking at both the cell biology and the behavioural patterns resulting from long-term use of MDMA or ecstasy.

The work is a collaboration between Victoria’s School of and School of Psychology and aims to better understand the changes ecstasy causes in the ’s neurochemistry and its impact on behaviour.

"Drug addiction research is exciting science and it’s also very relevant. Banning every mind-altering drug is not going to work so we need to find therapies to help people with their addiction.

"It’s a very complex field and there is a lot yet to understand about why some people who take drugs get addicted and others don’t."

Dr Kivell has had funding from the Neurological Foundation, the Wellington Research Foundation and the Health Research Council (HRC).

Provided by Victoria University

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Roll-your-own tobacco could be more addictive

Jan 12, 2011

Research carried out at Victoria University suggests smokers of roll-your-own tobacco may be more intensely addicted to the habit than those who puff on manufactured cigarettes.

A vaccine for nicotine?

Oct 04, 2011

(Medical Xpress) -- When Peter Burkhard first heard the idea of a nicotine vaccine eight years ago, he thought it was funny – how could a vaccine affect something that’s not technically a disease?

Discovering new drugs to fight TB

Aug 30, 2011

(Medical Xpress) -- Research at Victoria University is targeting new drugs to fight drug-resistant and other forms of tuberculosis (TB).

Abnormal brain structure linked to chronic cocaine abuse

Jun 21, 2011

Researchers at the University of Cambridge have identified abnormal brain structures in the frontal lobe of cocaine users' brains which are linked to their compulsive cocaine-using behaviour. Their findings were published ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.